UNSPSC 85872877: Fluoroscopy of hepatic artery using high osmolar contrast, laser intraoperative

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of hepatic artery using high osmolar contrast, laser intraoperativefluoroscopy of hepatic artery using high osmolar contrast, laser intraoperative. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code B412010

UNSPSC 85872877 Fluoroscopy of hepatic artery using high osmolar contrast, laser intraoperative is a Commodity code showing a substantial mismatch between its nominal scope and the state and local procurement activity tagged to it. The three most recent opportunities posted under this code do not solicit fluoroscopy imaging, hepatic artery procedures, or related clinical interventions. Instead, the opportunities cover diagnostic imaging system infrastructure (San Mateo Medical Center's PACS procurement), special education contracted services (Birdville Independent School District), and temporary health professional staffing across ancillary clinical categories (Santa Clara County Health System). The code appears to reflect a taxonomy or data-entry inconsistency rather than a meaningful purchasing category in state and local government procurement. No recent state and local contract opportunities in this source actually procure the fluoroscopy or interventional radiology services the code name describes.

The issuing bodies in the recent opportunities span a county hospital system, a school district, and a county health system across California and Texas. The mismatch between the code's clinical procedure focus and the actual work being solicited—systems integration, education services staffing, and temporary staffing across radiology, audiology, therapy, and other ancillary roles—suggests that practitioners pursuing opportunities under this code should verify the actual scope of work rather than rely on the code name alone. Business development teams evaluating this code should treat it as inactive for its stated clinical purpose and flag the taxonomy inconsistency with procurement offices before investing in pursuit strategy.